• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助性T细胞17在人类炎症性肠病发病机制中的作用

Role of Th17 Cells in the Pathogenesis of Human IBD.

作者信息

Gálvez Julio

机构信息

CIBER-EHD, Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, Avenida del Conocimiento s/n, Granada, 18100 Armilla, Spain.

出版信息

ISRN Inflamm. 2014 Mar 25;2014:928461. doi: 10.1155/2014/928461. eCollection 2014.

DOI:10.1155/2014/928461
PMID:25101191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4005031/
Abstract

The gastrointestinal tract plays a central role in immune system, being able to mount efficient immune responses against pathogens, keeping the homeostasis of the human gut. However, conditions like Crohn's disease (CD) or ulcerative colitis (UC), the main forms of inflammatory bowel diseases (IBD), are related to an excessive and uncontrolled immune response against normal microbiota, through the activation of CD4(+) T helper (Th) cells. Classically, IBD was thought to be primarily mediated by Th1 cells in CD or Th2 cells in UC, but it is now known that Th17 cells and their related cytokines are crucial mediators in both conditions. Th17 cells massively infiltrate the inflamed intestine of IBD patients, where they produce interleukin- (IL-) 17A and other cytokines, triggering and amplifying the inflammatory process. However, these cells show functional plasticity, and they can be converted into either IFN- γ producing Th1 cells or regulatory T cells. This review will summarize the current knowledge regarding the regulation and functional role of Th17 cells in the gut. Deeper insights into their plasticity in inflammatory conditions will contribute to advancing our understanding of the mechanisms that regulate mucosal homeostasis and inflammation in the gut, promoting the design of novel therapeutic approaches for IBD.

摘要

胃肠道在免疫系统中发挥着核心作用,能够对病原体发起有效的免疫反应,维持人体肠道的内环境稳定。然而,诸如克罗恩病(CD)或溃疡性结肠炎(UC)等炎症性肠病(IBD)的主要形式,与针对正常微生物群的过度且不受控制的免疫反应有关,这是通过CD4(+)辅助性T(Th)细胞的激活实现的。传统上,IBD被认为主要由CD中的Th1细胞或UC中的Th2细胞介导,但现在已知Th17细胞及其相关细胞因子在这两种疾病中都是关键的介质。Th17细胞大量浸润IBD患者发炎的肠道,在那里它们产生白细胞介素-(IL-)17A和其他细胞因子,引发并放大炎症过程。然而,这些细胞表现出功能可塑性,它们可以转化为产生干扰素-γ的Th1细胞或调节性T细胞。本综述将总结目前关于Th17细胞在肠道中的调节和功能作用的知识。对它们在炎症条件下可塑性的更深入了解将有助于推进我们对调节肠道黏膜内环境稳定和炎症机制的理解,促进IBD新型治疗方法的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/79b5b4dd97ce/ISRN.INFLAMMATION2014-928461.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/577682bda9ef/ISRN.INFLAMMATION2014-928461.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/12843e16fbd9/ISRN.INFLAMMATION2014-928461.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/72354610f495/ISRN.INFLAMMATION2014-928461.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/0660f1fe8300/ISRN.INFLAMMATION2014-928461.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/79b5b4dd97ce/ISRN.INFLAMMATION2014-928461.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/577682bda9ef/ISRN.INFLAMMATION2014-928461.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/12843e16fbd9/ISRN.INFLAMMATION2014-928461.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/72354610f495/ISRN.INFLAMMATION2014-928461.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/0660f1fe8300/ISRN.INFLAMMATION2014-928461.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e17/4005031/79b5b4dd97ce/ISRN.INFLAMMATION2014-928461.005.jpg

相似文献

1
Role of Th17 Cells in the Pathogenesis of Human IBD.辅助性T细胞17在人类炎症性肠病发病机制中的作用
ISRN Inflamm. 2014 Mar 25;2014:928461. doi: 10.1155/2014/928461. eCollection 2014.
2
Th17-related cytokines in inflammatory bowel diseases: friends or foes?Th17 相关细胞因子在炎症性肠病中的作用:是敌是友?
Curr Mol Med. 2012 Jun;12(5):592-7. doi: 10.2174/156652412800620066.
3
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
4
Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.全面的肠道辅助性T细胞分析揭示了在活动性炎症性肠病中产生IFN-γ+IL-17+的CD4+ T细胞的特异性聚集。
Inflamm Bowel Dis. 2014 Dec;20(12):2321-9. doi: 10.1097/MIB.0000000000000210.
5
Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.Th1 和 Th17 细胞因子在小儿炎症性肠病中的分隔表达。
Inflamm Bowel Dis. 2012 Jul;18(7):1260-6. doi: 10.1002/ibd.21905. Epub 2011 Oct 12.
6
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.Th1 和 Th17 细胞在炎症性肠病中的致病性和协同作用。
Inflamm Bowel Dis. 2023 May 2;29(5):818-829. doi: 10.1093/ibd/izac199.
7
Th17-related cytokines: new players in the control of chronic intestinal inflammation.Th17 相关细胞因子:慢性肠道炎症控制中的新角色。
BMC Med. 2011 Nov 15;9:122. doi: 10.1186/1741-7015-9-122.
8
Innate and adaptive immunity in inflammatory bowel disease.炎症性肠病中的先天免疫和适应性免疫。
Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15.
9
TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.TH1 和 TH17 细胞在炎症性肠病未治疗的炎症黏膜中的相互作用,及其介导炎症的潜力。
Cytokine. 2011 Dec;56(3):633-40. doi: 10.1016/j.cyto.2011.08.036. Epub 2011 Sep 25.
10
Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.智利克罗恩病和溃疡性结肠炎患者的外周细胞因子谱。
Eur Cytokine Netw. 2009 Mar;20(1):33-8. doi: 10.1684/ecn.2009.0142.

引用本文的文献

1
The Improvement of Intestinal Mucosal Epithelial Barrier Integrity by 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-]pyridazinone in Rat Experimental Colitis.吡咯并[3,4 - ]哒嗪酮的1,3,4 - 恶二唑衍生物对大鼠实验性结肠炎肠黏膜上皮屏障完整性的改善作用
J Inflamm Res. 2025 Jul 22;18:9735-9753. doi: 10.2147/JIR.S527041. eCollection 2025.
2
Current Challenges in Diagnosis and Treatment.诊断与治疗中的当前挑战
Microorganisms. 2025 May 15;13(5):1133. doi: 10.3390/microorganisms13051133.
3
The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021.

本文引用的文献

1
Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis.联合阻断白介素-17A 和白介素-17F 可能预防实验性结肠炎的发生。
Immunotherapy. 2013 Sep;5(9):923-5. doi: 10.2217/imt.13.87.
2
Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.间充质干细胞通过调节炎症和自身免疫反应缓解 TNBS 诱导的结肠炎。
World J Gastroenterol. 2013 Aug 7;19(29):4702-17. doi: 10.3748/wjg.v19.i29.4702.
3
Inhibition of IL-17 as a pharmacological approach for IBD.抑制白介素-17 作为炎症性肠病的一种药理学方法。
新冠疫情两年后自身免疫性疾病全球负担的变化:基于《2021年全球疾病负担研究》的趋势分析
J Transl Autoimmun. 2025 Apr 24;10:100289. doi: 10.1016/j.jtauto.2025.100289. eCollection 2025 Jun.
4
The Use of Potent Populations of Expanded Fetal Human Placental Stromal Cells for the Treatment of Dextran Sodium Sulfate-Induced Colitis in a Mouse Model.使用扩增的胎儿人胎盘基质细胞的有效群体治疗小鼠模型中葡聚糖硫酸钠诱导的结肠炎。
Int J Mol Sci. 2025 Mar 30;26(7):3222. doi: 10.3390/ijms26073222.
5
RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination.RTF1通过H2B单泛素化介导Th17细胞分化的表观遗传调控。
J Immunol. 2025 Feb 24;214(3):460-71. doi: 10.1093/jimmun/vkae043.
6
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions.炎症性肠病中预测反应的发病机制与精准医学:进展与未来方向
eGastroenterology. 2024 Jan 18;2(1):e100006. doi: 10.1136/egastro-2023-100006. eCollection 2024 Jan.
7
Translating Human and Animal Model Studies to Dogs' and Cats' Veterinary Care: Beta-Glucans Application for Skin Disease, Osteoarthritis, and Inflammatory Bowel Disease Management.将人类和动物模型研究转化为犬猫的兽医护理:β-葡聚糖在皮肤病、骨关节炎和炎症性肠病管理中的应用。
Microorganisms. 2024 May 25;12(6):1071. doi: 10.3390/microorganisms12061071.
8
How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer.西方饮食如何破坏溃疡性结肠炎肠道微生物的表观遗传学作用及其与结直肠癌的关系。
Biomolecules. 2024 May 29;14(6):633. doi: 10.3390/biom14060633.
9
A broken network of susceptibility genes in the monocytes of Crohn's disease patients.克罗恩病患者单核细胞中易感性基因的断裂网络。
Life Sci Alliance. 2024 Jun 26;7(9). doi: 10.26508/lsa.202302394. Print 2024 Sep.
10
The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.遗传因素与生物制剂治疗银屑病、银屑病关节炎、类风湿关节炎和炎症性肠病患者反应的相关性:系统评价和荟萃分析。
Int J Mol Sci. 2024 May 26;25(11):5793. doi: 10.3390/ijms25115793.
Int Rev Immunol. 2013 Oct-Dec;32(5-6):544-55. doi: 10.3109/08830185.2013.821118. Epub 2013 Jul 25.
4
IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.在活动性炎症性结肠炎组织中,IL-22 产生的 CD4+ 细胞被耗尽。
Mucosal Immunol. 2014 Jan;7(1):124-33. doi: 10.1038/mi.2013.31. Epub 2013 May 22.
5
TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.实验性结肠炎中 TH17 细胞的诱导及 IL-17A 和 IL-17F 阻断的作用。
Inflamm Bowel Dis. 2013 Jul;19(8):1567-76. doi: 10.1097/MIB.0b013e318286fa1c.
6
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.辅助性 T 细胞 17 通路与肠道、肺部和皮肤的炎症性疾病。
Annu Rev Pathol. 2013 Jan 24;8:477-512. doi: 10.1146/annurev-pathol-011110-130318. Epub 2012 Nov 15.
7
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.在炎症性肠病患者中 vidofludimus 的疗效、安全性和耐受性:ENTRANCE 研究。
J Crohns Colitis. 2013 Sep;7(8):636-43. doi: 10.1016/j.crohns.2012.09.016. Epub 2012 Oct 16.
8
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.乌司奴单抗诱导和维持治疗难治性克罗恩病。
N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.
9
Reciprocal interactions of the intestinal microbiota and immune system.肠道微生物群和免疫系统的相互作用。
Nature. 2012 Sep 13;489(7415):231-41. doi: 10.1038/nature11551.
10
The gut microbiota in IBD.炎症性肠病中的肠道微生物群。
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):599-608. doi: 10.1038/nrgastro.2012.152. Epub 2012 Aug 21.